News

We explore how Celemics' pathogen-specific panel design framework addresses key challenges such as high mutation rates, host background interference, and coverage variability—across both hybridization capture and amplicon-based sequencing approaches.

As regulatory expectations continue to evolve in the U.S., clinical laboratories and LDT developers increasingly require reagents and panels that support quality systems, traceability, and documentation. FDA Class I listing...